Brief: Bluejay Diagnostics Reports Third Quarter Results
Nov 9 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS, INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS
* BLUEJAY DIAGNOSTICS INC Q3 LOSS PER SHARE $0.15
* BLUEJAY DIAGNOSTICS INC- EXPECTS THAT CASH POSITION WILL
BE
SUFFICIENT TO FUND OPERATIONS FOR NEXT 12 MONTHS
Source text for Eikon: ID:nGNXb7Wx1d
Further company coverage: BJDX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook